CTO: Length’s Impact on Success

The rise of chronic total occlusions (CTO) percutaneous coronary interventions (PCI) goes hand in hand with technological development, through still posing a great challenge, one not exactly exempt from complications. 

CTO: la longitud impacta en el éxito

An important criterion to successful CTO PCI is length: ≥20 mm lesions lower the odds, according to J-CTO Score. However, increasing operator experience and the development of new guidewires and micro-catheters is gradually changing the situation.

The study looked at 10335 CTO PCI performed between 2012 and 2022. 7208 of these interventions were ≥20 mm long (69.7%) and 3127 <20 mm long (30.3%).

Mean age was similar in both groups, but those with ≥20 mm occlusions were more often men, smokers, presenting hypertension, dyslipidemia, diabetes, peripheral vascular disease, cardiac failure, lower ejection fraction, MI, and CABG. 

The artery that more frequently presented CTO was the right coronary (57.3%), followed by the anterior descending (23.4%) and the circumflex.

Read also: ISAR Score: Can We Predict the Need for Repeat PCI in DES Restenosis?

≥20 mm occlusions presented more unfavorable angiographic characteristics, more tortuosity, and severe calcification. Also, the dissection and reentry technique was more often used in the group, as well as the retrograde strategy.

Crossing success rate was lower in patients presenting longer lesions, who also needed more stents, longer fluoroscopy time and longer procedures. 

≥20 mm lesions were associated to lower technical and procedural success (84.4% vs. 91.8%; p < 0.001 and 81.9% vs. 90.3%; p < 0.001 respectively). In hospital MACE was higher in this group (3.4% vs. 1.9%; p < 0.001), as was AMI (0.7% vs. 0.26%; p = 0.009), perforations (5.15% vs. 3.87%; p = 0.007) and the presence of thrombi and dissection (0.84% vs. 0.35%; p = 0.008).

Read also: Percutaneous Access Closure in TAVR: Are Devices Similar?

A 10 mm increase in occlusion length was associated to lower technical success rate. 

After multivariable analysis, (shorter) lesion length was associated to reduced MACE and technical success. 

Conclusion

CTO PCI of long occlusions is independently associated with lower rates of technical success and higher rates of in-hospital MACE. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS‐CTO registry.

Reference: Athanasios Rempakos, et al. Catheter Cardiovasc Interv. 2023;101:747–755.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...